Telix Receives FDA's Fast Track Designation For Its BiPASS Program To Trace Prostate Cancer Prior To Biopsy

Benzinga Newsdesk www.benzinga.com Neutral 91.3%

Neg 0% Neu 91.3% Pos 0%

https://telixpharma.com/news-views/telix-granted-fda-fast-track-designation-for-bipass-pre-biopsy-prostate-cancer-imaging/